Cargando…

Linoleate appears to protect against palmitate-induced inflammation in Huh7 cells

BACKGROUND: Polyunsaturated fatty acids (PUFAs) may protect against metabolic diseases. Although the benefits of the n-3 family of PUFA have been well investigated in nonalcoholic steatohepatitis (NASH), little is known about the effect of the n-6 family. This study examined the effect of linoleate,...

Descripción completa

Detalles Bibliográficos
Autores principales: Maruyama, Hitoshi, Takahashi, Masanori, Sekimoto, Tadashi, Shimada, Taro, Yokosuka, Osamu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4038110/
https://www.ncbi.nlm.nih.gov/pubmed/24885871
http://dx.doi.org/10.1186/1476-511X-13-78
_version_ 1782318328054808576
author Maruyama, Hitoshi
Takahashi, Masanori
Sekimoto, Tadashi
Shimada, Taro
Yokosuka, Osamu
author_facet Maruyama, Hitoshi
Takahashi, Masanori
Sekimoto, Tadashi
Shimada, Taro
Yokosuka, Osamu
author_sort Maruyama, Hitoshi
collection PubMed
description BACKGROUND: Polyunsaturated fatty acids (PUFAs) may protect against metabolic diseases. Although the benefits of the n-3 family of PUFA have been well investigated in nonalcoholic steatohepatitis (NASH), little is known about the effect of the n-6 family. This study examined the effect of linoleate, a member of the n-6 family, on regulation of the palmitate-induced inflammatory cytokine interleukin-8 (IL8) in hepatocytes. METHODS: Huh7 cells and HepG2 cells were cultured with and without free fatty acid treatment (palmitate and linoleate, alone or in combination, 100–1000 μM). Inflammatory pathways, lipid accumulation, apoptosis and cell viability were monitored. RESULTS: Dose- and time-related changes of IL8 mRNA expression were examined and 9 h treatment with 500 μM palmitate showed the greatest elevation of IL8. Co-treatment with 500 μM palmitate and 400 μM linoleate significantly suppressed IL8 production below that with palmitate alone in both cells (both mRNA and protein). A quantitative measurement for lipid accumulation showed no significant difference between palmitate-treated cells (1.69 ± 0.21), linoleate-treated cells (1.61 ± 0.16) and palmitate and linoleate-treated cells (1.73 ± 0.22, NS, n = 7). The co-treatment with 400 μM linoleate inhibited phospho-c-Jun N-terminal kinase (pJNK) activation and IkBα reduction caused by 500 μM palmitate treatment. Treatment with 400 μM linoleate alone led to IL8 production (5.48 fold change), similar to co-treatment, with no influence on the expression of pJNK/IkBα. The cell viability was similar between treatment with 500 μM palmitate and with both 500 μM palmitate and 400 μM linoleate, showing no significant changes in the expression of cleaved caspase-3. CONCLUSIONS: Linoleate is a potent regulator of the proinflammatory cytokine IL8 via the JNK and nuclear factor kappa B pathways that are involved in the pathophysiology of NASH, suggesting a future recommendation of dietary management.
format Online
Article
Text
id pubmed-4038110
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-40381102014-05-30 Linoleate appears to protect against palmitate-induced inflammation in Huh7 cells Maruyama, Hitoshi Takahashi, Masanori Sekimoto, Tadashi Shimada, Taro Yokosuka, Osamu Lipids Health Dis Research BACKGROUND: Polyunsaturated fatty acids (PUFAs) may protect against metabolic diseases. Although the benefits of the n-3 family of PUFA have been well investigated in nonalcoholic steatohepatitis (NASH), little is known about the effect of the n-6 family. This study examined the effect of linoleate, a member of the n-6 family, on regulation of the palmitate-induced inflammatory cytokine interleukin-8 (IL8) in hepatocytes. METHODS: Huh7 cells and HepG2 cells were cultured with and without free fatty acid treatment (palmitate and linoleate, alone or in combination, 100–1000 μM). Inflammatory pathways, lipid accumulation, apoptosis and cell viability were monitored. RESULTS: Dose- and time-related changes of IL8 mRNA expression were examined and 9 h treatment with 500 μM palmitate showed the greatest elevation of IL8. Co-treatment with 500 μM palmitate and 400 μM linoleate significantly suppressed IL8 production below that with palmitate alone in both cells (both mRNA and protein). A quantitative measurement for lipid accumulation showed no significant difference between palmitate-treated cells (1.69 ± 0.21), linoleate-treated cells (1.61 ± 0.16) and palmitate and linoleate-treated cells (1.73 ± 0.22, NS, n = 7). The co-treatment with 400 μM linoleate inhibited phospho-c-Jun N-terminal kinase (pJNK) activation and IkBα reduction caused by 500 μM palmitate treatment. Treatment with 400 μM linoleate alone led to IL8 production (5.48 fold change), similar to co-treatment, with no influence on the expression of pJNK/IkBα. The cell viability was similar between treatment with 500 μM palmitate and with both 500 μM palmitate and 400 μM linoleate, showing no significant changes in the expression of cleaved caspase-3. CONCLUSIONS: Linoleate is a potent regulator of the proinflammatory cytokine IL8 via the JNK and nuclear factor kappa B pathways that are involved in the pathophysiology of NASH, suggesting a future recommendation of dietary management. BioMed Central 2014-05-13 /pmc/articles/PMC4038110/ /pubmed/24885871 http://dx.doi.org/10.1186/1476-511X-13-78 Text en Copyright © 2014 Maruyama et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Maruyama, Hitoshi
Takahashi, Masanori
Sekimoto, Tadashi
Shimada, Taro
Yokosuka, Osamu
Linoleate appears to protect against palmitate-induced inflammation in Huh7 cells
title Linoleate appears to protect against palmitate-induced inflammation in Huh7 cells
title_full Linoleate appears to protect against palmitate-induced inflammation in Huh7 cells
title_fullStr Linoleate appears to protect against palmitate-induced inflammation in Huh7 cells
title_full_unstemmed Linoleate appears to protect against palmitate-induced inflammation in Huh7 cells
title_short Linoleate appears to protect against palmitate-induced inflammation in Huh7 cells
title_sort linoleate appears to protect against palmitate-induced inflammation in huh7 cells
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4038110/
https://www.ncbi.nlm.nih.gov/pubmed/24885871
http://dx.doi.org/10.1186/1476-511X-13-78
work_keys_str_mv AT maruyamahitoshi linoleateappearstoprotectagainstpalmitateinducedinflammationinhuh7cells
AT takahashimasanori linoleateappearstoprotectagainstpalmitateinducedinflammationinhuh7cells
AT sekimototadashi linoleateappearstoprotectagainstpalmitateinducedinflammationinhuh7cells
AT shimadataro linoleateappearstoprotectagainstpalmitateinducedinflammationinhuh7cells
AT yokosukaosamu linoleateappearstoprotectagainstpalmitateinducedinflammationinhuh7cells